Statin Therapy

Initiation of high-intensity statin therapy during the acute phase of minor, noncardiogenic stroke may increase bleeding risk, according to the results of a Chinese cohort study published in the Journal of the American Heart Association.

Statin initiation in patients with stroke etiologies not indicated for secondary prevention with statin therapy could hypothetically cause thousands of adverse events every year, according to a new meta-analysis published in Stroke.

Icosapent ethyl significantly reduced coronary events and led to numerically fewer CV events at 5 years for patients with CAD and low plasma eicosapentaenoic acid already taking statin therapy, researchers reported.

The National Lipid Association has issued a clinical consensus statement on the management of dyslipidemia in women of reproductive potential, with a focus on considerations for pharmacologic options, a speaker reported.

Fewer U.S. adults aged 40 to 75 years are eligible for statin therapy for primary CVD prevention in the new PREVENT risk calculator compared with the older Pooled Cohort Equation, researchers reported.

PHILADELPHIA — Despite there being few options to directly lower lipoprotein(a) as of yet, measurement is none the less important to identify those who would benefit from improved risk factor control, a speaker reported.

Statins were associated with a reduced risk for CVD and death in older adults, even those aged 85 years and older, data in Annals of Internal Medicine showed.

WASHINGTON — Statin use was associated with up to a 90% risk reduction for new-onset primary sclerosing cholangitis among patients with inflammatory bowel disease, according to data presented at Digestive Disease Week.

ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from the ROSE2 trial.